Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin I
Tóm tắt
Từ khóa
Tài liệu tham khảo
Karmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S., Lior, H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin producingEscherichia coli. J. Infect. Dis 151 (1985) 775–782.
Koster, F., Levin, J., Walker, L. Hemolytic uremic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N. Engl. J. Med. 298 (1978) 927–933.
Lopez, E. L., Diaz, M., Grinstein, S., Devoto, S., Mendilaharzu, F., Murray, B. E., Ashkenazi, S., Rubeglio, E., Woloj, M., Vasquez, M., Turco, M., Pickering, L. K., Cleary, T. G. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of shiga-like toxins. J. Infect. Dis. 160 (1989) 469–475.
Butler, T., Islam, M. R., Azad, M. A. K., Jones, P. K. Risk factors for development of hemolytic uremic syndrome during shigellosis. J. Pediatr. 110 (1987) 894–897.
Carter, A. O., Borczyk, A. A., Carlson, J. A. K., Harvey, B., Hockin, J. C., Karmali, M. A., Krishnan, C., Korn, D. A., Lior, H. A severe outbreak ofEscherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N. Engl. J. Med. 317 (1987) 1496–1500.
Pavia, A. T., Nichols, C. R., Green, D. P., Tauxe, R. V., Mottice, S., Green, K. D., Wells, J. G., Siegler, R. L., Brewer, E. D., Hannon, D., Blake, P. A. Hemolytic-uremic syndrome during an outbreak ofEscherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J. Pediatr. 116 (1989) 544–551.
Cimolai, N., Carter, J. E., Morrison, B. J., Anderson, J. D. Risk factors for the progression ofEscherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J. Pediatr. 116 (1988) 589–592.
Ostroff, S. M., Kobayashi, J. M., Lewis, J. H. Infections withEscherichia coli O157:H7 in Washington State: the first year of statewide disease surveillance. JAMA 262 (1989) 355–359.
Karch, H., Goroncy-Bermes, P., Opferkuch, W., Kroll, H. P., O'Brien, A. Subinhibitory concentrations of antibiotics modulate amount of shiga-like toxin produced byEscherichia coli. In:Adam, D., Hahn, H., Opferkuch, W. (eds.): The influence of antibiotics on the host-parasite relationship II. Springer-Verlag, Berlin 1985, pp. 239–245.
Karch, H., Strockbine, N. A., O'Brien, A. D. Growth ofEscherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of shiga-like toxin producing strains by colony blot assay. FEMS Microbiol. Lett. 141 (1986) 141–145.
Lorian, V., Gray, N. Increased bacterial density at the edge of antibiotic zones of inhibition. J. Bacteriol. 92 (1966) 1256–1257.
Newland, J. W., Neill, R. D. DNA probes for shiga-like toxins I and II and for toxin converting bacteriophages. J. Clin. Microbiol. 26 (1988) 1292–1297.
Ashkenazi, S., Cleary, T. G. Rapid method to detect shiga toxins and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. J. Clin. Microbiol. 27 (1989) 1145–1150.
Greenwood, D., O'Grady, F. A comparison of the effects of ampicillin onEscherichia coli andProteus mirabilis. J. Med. Microbiol. 2 (1969) 435–441.
Zimmerman, S. B., Stapley, O. Relative morphological effects induced by cefoxitin and other β-lactam antibioticsin vitro. Antimicrob. Agents Chemother. 9 (1976) 318–326.
Lorian, V. Some effects of subinhibitory concentrations of penicillin on the structure and division of staphylococci. Antimicrob. Agents Chemother. 7 (1975) 864–870.
Lorian, V. Effect of antibiotics on bacterial structure. In:Root, R. K., Sande, M. A. (eds.): New dimensions in antimicrobial therapy. Churchill Livingstone, New York 1984, pp. 37–81.
Lorian, V., Atkinson, B. Abnormal forms of bacteria produced by antibiotics. Am. J. Clin. Pathol. 64 (1975) 678–688.
Lorian, V. Effect of low antibiotic concentration on bacteria: effects on ultrastructure, their virulence and susceptibility to immunodeficiencies. In:Lorian, V. (ed.): Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore 1985, pp. 596–668.
Morgan, C., Rosenkranz, H. S., Carr, H. S., Rose, H. M. Electron microscopy of chloramphenicol-treatedEscherichia coli. J. Bacteriol. 93 (1967) 1987.
Yoh, M., Yamamoto, K., Honda, T., Takeda, Y., Niwatani, T. Effects of lincomycin and tetracycline on production and properties of enterotoxins of enterotoxigenicEschericha coli. Infect. Immun. 42 (1983) 778–782.
Levner, M., Urbano, C., Rubin, B. A. Lincomycin increases synthetic rate and periplasmic pool size of cholera toxin. J. Bacteriol. 143 (1980) 441–447.
George, R. H., Johnson, M., Young, D., Burdon, D. W. Induction ofClostridium difficile toxin by antibiotics. Current chemotherapy and infectious disease. In:Nelson, J. D., Grassi, C. (eds.): Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy (Volume 2), Boston, October 1979. American Society for Microbiology, Washington D. C. 1980, pp. 955–956.
Jurgens, K. R., Baez, J. A. Use of fluoroquinolones improves productivity of a Rec A promoter regulated intracellular recombinant protein inE. coli. ASM Conference on Biotechnology, Chicago, June 7–10, 1990. American Society for Microbiology, Washington D. C. 1990, Abstract no. 24, p. 14, 1990.
Tzipori, S., Gibson, R., Montanaro, J. Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagicEscherichia coli in piglets and the role of plasmid-mediated factors. Infect. Immun. 57 (1989) 1142–1150.
Sandberg, T., Stenquist, R., Svanborg Eden, C. Effects of subminimal inhibitory concentrations of ampicillin, chloramphenicol and nitrofurantion on the attachment ofEscherichia coli to human uroepithelial cellsin vitro. Rev. Infect. Dis. 1 (1979) 838–844.